| ESMYX | TRZPX | ESMYX / TRZPX | |
| Total Expense Ratio | 1.00 | 0.00 | - |
| Annual Report Gross Expense Ratio | 1.19 | 0.84 | 142% |
| Fund Existence | 18 years | 5 years | - |
| Gain YTD | 12.272 | 8.666 | 142% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 164M | 890M | 18% |
| Annual Yield % from dividends | 3.36 | 2.62 | 128% |
| Returns for 1 year | -14.14 | 6.90 | -205% |
| Returns for 3 years | 7.84 | 21.28 | 37% |
| Returns for 5 years | -5.55 | 9.46 | -59% |
| Returns for 10 years | 44.24 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GLVAX | 83.58 | 1.46 | +1.78% |
| Invesco Global Focus A | |||
| BMGCX | 15.59 | 0.06 | +0.39% |
| BlackRock Mid-Cap Growth Equity Inv C | |||
| RLBEX | 40.33 | 0.07 | +0.17% |
| American Funds American Balanced R-4 | |||
| VSFCX | 25.95 | -0.09 | -0.35% |
| Federated Hermes MDT Small Cap Value C | |||
| PJHRX | 34.45 | -0.39 | -1.12% |
| PGIM Jennison Health Sciences R | |||